{{Otheruses|subject=转基因技术|other=转基因改造食品|基因改造食品}}
{{noteTA
|1=zh-tw:基因改造;zh-cn:遗传修饰;
}}
{{Genetics sidebar}}

'''基因工程'''（{{lang-en|Gene engineering}}）又称'''遺傳工程'''（{{lang-en|Genetic engineering}}）<ref>{{Cite web |url=https://www.termonline.cn/word/376274/1#s1 |title=存档副本 |access-date=2021-09-30 |archive-date=2022-03-10 |archive-url=https://web.archive.org/web/20220310053225/https://www.termonline.cn/word/376274/1#s1 }}</ref>{{NoteTag|1=严格地说，「遗传工程」所涉及的范围比「基因工程」广泛，两者略有差别。遗传工程的目标是改变机体性状特征，其为遗传-{信息}-内容的操作，不但包括常规的选择育种，也包括了较复杂的基因-{克隆}-（选殖）的不同技术层次。}}、'''基因操作'''、'''基因修饰'''、'''重组核酸技术'''，是一種使用[[生物技术|生物技术]]直接操纵[[有机体|有机体]]基因组、用于改变细胞[[遗传物质|遗传物质]]的工程；此工程技术可以通过使用[[分子克隆|分子克隆]]技术分离和复制需要的遗传物质以产生[[核酸序列|核酸序列]]，也可以藉由生物工程学方法设计并合成核酸序列，然后以此“外源DNA或RNA”将新的遗传物质插入[[宿主|宿主]]基因组中，使同一物种或跨物种的[[基因|基因]]转移，以产生改良的或新的生物体。

基因工程步骤中，可另外使用[[核酸酶|核酸酶]]除去或“敲除”基因；也可进行扩增而制备大量纯化的DNA或RNA片段；更可将靶核酸分子或重组核酸分子插入基因工程[[运载体|载体]]，接着再导入[[宿主|宿主]]甚或插入宿主核酸中。[[基因靶向|基因靶向]]则是使用同源重组来改变内源基因的不同技术，并且可以用于缺失基因，去除[[外显子|外显子]]，添加基因或引入[[点突变|点突变]]。

通过基因工程产生的[[生物体|生物体]]被认为是“[[遗传修饰生物体|遗传修饰生物体]]”（GMO）又称“转基因生物”。第一种遗传修饰生物是1973年产生的[[细菌|细菌]]和1974年的遗传修饰[[小鼠|小鼠]]。利用细菌产生[[胰岛素|胰岛素]]在1982年商业化，遗传修饰食品自1994年以来一直销售。作为宠物设计的第一种遗传修饰生物GloFish于2003年12月首先在[[美国|美国]]销售。<ref>{{cite news|title=First transgenic pet, ‘GloFish’, sold to US public|url=http://www.phgfoundation.org/news/1304/|newspaper=PHG Foundation|date=2004-01-09|deadurl=yes|archiveurl=https://web.archive.org/web/20130615032218/http://www.phgfoundation.org/news/1304|archivedate=2013-06-15|accessdate=2017-02-08}}</ref>

基因工程技术建立在[[分子生物学|分子生物学]]、[[分子遗传学|分子遗传学]]、基因分子[[生化学|生化学]]的知识进展上，其已应用于许多领域，包括[[研究|研究]]、[[农业|农业]]、工业生物技术和[[医学|医学]]。用于洗衣洗涤剂和药物如胰岛素和人生长激素的[[酶|酶]]现在在遗传修饰（GM）细胞中制造，实验性遗传修饰细胞系和遗传修饰动物例如小鼠或[[斑马鱼|斑马鱼]]正用于研究目的，并且遗传修饰作物已经商业化。

== 定义 ==
{{Quote box
 |title = [[國際純化學和應用化學聯合會|國際純化學和應用化學聯合會]] 定义
 |quote = 将新的遗传信息插入现有细胞以便修改特定生物体以改变其特征的过程。<ref>{{cite web|website=U.S. Environmental Protection Agency online|title=Terms and Acronyms|url=http://www.epa.gov/OCEPAterms/gterms.html|access-date=2015-07-16|archive-date=2011-07-20|archive-url=https://web.archive.org/web/20110720135358/http://www.epa.gov/OCEPATERMS/gterms.html}}</ref><ref>{{cite journal|title=Terminology for biorelated polymers and applications (IUPAC Recommendations 2012)|journal=[[纯粹与应用化学|纯粹与应用化学]]|year=2012|volume=84|issue=2|pages=377–410|doi=10.1351/PAC-REC-10-12-04|url=http://pac.iupac.org/publications/pac/pdf/2012/pdf/8402x0377.pdf|last1=Vert|first1=Michel|last2=Doi|first2=Yoshiharu|last3=Hellwich|first3=Karl-Heinz|last4=Hess|first4=Michael|last5=Hodge|first5=Philip|last6=Kubisa|first6=Przemyslaw|last7=Rinaudo|first7=Marguerite|last8=Schué|first8=François|access-date=2017-02-08|archive-date=2015-03-19|archive-url=https://web.archive.org/web/20150319032817/http://pac.iupac.org/publications/pac/pdf/2012/pdf/8402x0377.pdf|dead-url=no}}</ref>

}}
[[File:Breeding_transgenesis_cisgenesis.svg|thumb]]
基因工程是改变生物的遗传组成使用的技术，包括了删除可遗传材料，和将生物体外直接制备的DNA导入[[宿主|宿主]]或[[细胞|细胞]]，然后与宿主融合或[[杂交|杂交]]。<ref name = "EU17">{{Cite journal|title=Directive on the release of genetically modified organisms (GMOs) Directive 2001/18/EC ANNEX I A|publisher=Official Journal of the European Communities|date=2001-03-12|author=The European Parliament and the council of the European Union|url=http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:106:0001:0038:EN:PDF|page=17|postscript=<!--None-->|journal=|access-date=2017-02-08|archive-url=https://web.archive.org/web/20170723050044/http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:106:0001:0038:EN:PDF|archive-date=2017-07-23|dead-url=yes}}</ref> 这涉及使用重组核酸（DNA或RNA）技术来形成可遗传材料的新组合，然后通过[[运载体|载体]]系统（基因工程载体）间接地或通过显微注射、大量注射和[[微囊化技术|微囊化技术]]直接地掺入该材料。

“基因工程”並不包括传统的动物和植物育种、[[体外受精|体外受精]]、[[染色體倍性|多倍体]]育种、[[人工诱变|人工诱变]]和[[細胞融合|细胞融合]]技术，因为在该过程中不使用经过重组核酸或遗传修饰的生物体。<ref name = "EU17"/>[[欧洲联盟|欧盟]]则将“遗传工程”广泛定义为包括[[选择育种|选择育种]]和其他人工选择手段；严格说来，遗传工程（genetic engineering）的范围较基因工程（gene engineering）广泛。<ref>Staff [http://ec.europa.eu/agriculture/publi/gmo/gmo.pdf Economic Impacts of Genetically Modified Crops on the Agri-Food Sector; P. 42 Glossary - Term and Definitions] {{Wayback|url=http://ec.europa.eu/agriculture/publi/gmo/gmo.pdf |date=20130514202621 }} The European Commission Directorate-General for Agriculture, "Genetic engineering: The manipulation of an organism's genetic endowment by introducing or eliminating specific genes through modern molecular biology techniques. A broad definition of genetic engineering also includes selective breeding and other means of artificial selection.",  Retrieved 5 November 2012</ref>[[克隆|克隆]]和[[干细胞|干细胞]]技术，虽然不被认为是基因工程，<ref>{{cite web|title=Is Livestock Cloning Another Form of Genetic Engineering?|last=VanEenennaam|first=Alison|publisher=agbiotech|url=http://agribiotech.info/details/Alison%20%20cloning%20March%208%20%2003.pdf|accessdate=|deadurl=yes|archiveurl=https://web.archive.org/web/20110511121055/http://agribiotech.info/details/Alison%20-%20cloning%20March%208%20-%2003.pdf|archivedate=2011-05-11}}</ref>但也是与基因工程密切相关的，可以在其中使用基因工程。<ref>{{cite journal|journal=Swiss Med Wkly|year=2006|volume=136|issue=27–28|pages=413–415|title=Genetic engineering of embryonic stem cells|first1=David M.|last1=Suter|first2=Michel|last2=Dubois-Dauphin|first3=Karl-Heinz|last3=Krause|url=http://www.smw.ch/docs/pdf200x/2006/27/smw-11406.PDF|pmid=16897894|access-date=2017-02-08|archive-date=2011-07-07|archive-url=https://web.archive.org/web/20110707003215/http://www.smw.ch/docs/pdf200x/2006/27/smw-11406.PDF|dead-url=no}}</ref> [[合成生物学|合成生物学]]是一个新兴的学科，它使基因工程进一步将人工合成的材料从原材料引入生物体。

如果将来自另一物种的遗传物质添加到某生物体中，则所得生物称为遗传修饰生物。如果使用来自相同物种的遗传物质或可以与宿主自然[[繁殖|繁殖]]的物种，则称为[[同源基因|同源基因]]改造<ref>{{cite journal |doi=10.1007/s11540-008-9097-y |title=Cisgenesis, a New Tool for Traditional Plant Breeding, Should be Exempted from the Regulation on Genetically Modified Organisms in a Step by Step Approach |year=2008 |last1=Jacobsen |first1=E. |last2=Schouten |first2=H. J. |journal=Potato Research |volume=51 |pages=75–88}}</ref>遗传工程也可以用于从目标生物体去除遗传物质，创建一个基因敲除生物体<ref>{{cite journal |doi=10.1038/nm1001-1086 |year=2001 |last1=Capecchi |first1=Mario R. |journal=Nature Medicine |volume=7 |issue=10 |pages=1086–90 |pmid=11590420 |title=Generating mice with targeted mutations}}</ref>在欧洲，遗传修饰是遗传工程的同义词，而在[[美国|美国]]，“基因修饰”一词也可以指常规的育种方法。<ref>Staff [http://www.usda.gov/wps/portal/usda/usdahome?contentid=BiotechnologyGlosary.xml&navid= Biotechnology - Glossary of Agricultural Biotechnology Terms] {{Wayback|url=http://www.usda.gov/wps/portal/usda/usdahome?contentid=BiotechnologyGlosary.xml&navid= |date=20140830102928 }} United States Department of Agriculture, "Genetic modification: The production of heritable improvements in plants or animals for specific uses, via either genetic engineering or other more traditional methods. Some countries other than the United States use this term to refer specifically to genetic engineering.", Retrieved 5 November 2012</ref><ref>{{cite web|title=Genetically Engineered Foods|first=James H.|last=Maryanski|publisher=Center for Food Safety and Applied Nutrition at the [[美国食品药品监督管理局|美国食品药品监督管理局]]|date=1999-10-19|url=http://www.fda.gov/NewsEvents/Testimony/ucm115032.htm|accessdate=2017-02-08|archive-date=2011-02-22|archive-url=https://web.archive.org/web/20110222202827/http://www.fda.gov/NewsEvents/Testimony/ucm115032.htm|dead-url=no}}</ref>[[加拿大|加拿大]]的监管制度是基于产品是否具有新颖的特征，而不管来源的方法。换句话说，如果产品携带一些先前在物种中未发现的[[性狀|性状]]，则其被调节为遗传修饰，无论其是使用传统育种方法（例如选择育种，细胞融合，突变育种）还是遗传工程产生的。<ref>Evans, Brent and Lupescu, Mihai (15 July 2012) [http://gain.fas.usda.gov/Recent%20GAIN%20Publications/Agricultural%20Biotechnology%20Annual_Ottawa_Canada_07-20-2012.pdf Canada - Agricultural Biotechnology Annual – 2012] {{Wayback|url=http://gain.fas.usda.gov/Recent%20GAIN%20Publications/Agricultural%20Biotechnology%20Annual_Ottawa_Canada_07-20-2012.pdf |date=20131215160309 }} GAIN (Global Agricultural Information Network) report CA12029, United States Department of Agriculture, Foreifn Agricultural Service, Retrieved 5 November 2012</ref><ref>{{cite book |last=McHugen |first=Alan |title= Pandora's Picnic Basket |publisher=Oxford University Press |date=2000-09-14 |chapter=Chapter 1: Hors-d'oeuvres and entrees/What is genetic modification?  What are GMOs? |isbn=978-0198506744}}</ref><ref>Staff (28 November 2005) [http://www.hc-sc.gc.ca/sr-sr/pubs/biotech/reg_gen_mod-eng.php Health Canada - The Regulation of Genetically Modified Food] {{Wayback|url=http://www.hc-sc.gc.ca/sr-sr/pubs/biotech/reg_gen_mod-eng.php |date=20170610170104 }} Glossary definition of Genetically Modified: "An organism, such as a plant, animal or bacterium, is considered genetically modified if its genetic material has been altered through any method, including conventional breeding. A 'GMO' is a genetically modified organism.", Retrieved 5 November 2012</ref>在科学界，“基因工程”这个术语并不常用。取而代之的是更为具体的术语，例如“遗传修饰”或“转基因”。

== 歷史 ==
{{main article|基因工程历史}}

数千年来，人类通过选择性育种或人工选择。<ref name=Root>{{cite book|title=Domestication|url={{google books |plainurl=y |id=WGDYHvOHwmwC}}|first=Clive |last=Root|year=2007|publisher=Greenwood Publishing Groups}}</ref>{{rp|1}}<ref name=Zohary>{{cite book |title=Domestication of Plants in the Old World: The origin and spread of plants in the old world|url={{google books |plainurl=y |id=tc6vr0qzk_4C}}|first1=Daniel |last1=Zohary |first2=Maria |last2=Hopf |first3=Ehud |last3=Weiss|year=2012|publisher=Oxford University Press}}</ref>近年来，逐渐通过诱变改变了物种的基因组。而遗传工程作为直接操纵DNA、由人外部育种和突变是自20世纪70年代产生的。

“遗传工程”这个术语最早由[[杰克·威廉姆森|杰克·威廉姆森]]在1951年——也就是DNA在在遗传中的作用得到了[[阿弗雷德·赫希|阿弗雷德·赫希]]和[[玛莎·蔡斯|玛莎·蔡斯]]的证实的前一年——出版的科幻小说“龙之岛<ref>{{cite book|last=Stableford|first=Brian M.|first-link=|title=Historical dictionary of science fiction literature|page=133|year=2004|isbn=9780810849389|url={{google books |plainurl=y |id=nzmIPZg5xicC|page=9}}}}</ref>中创作。1953年，[[詹姆斯·沃森|詹姆斯·沃森]]和[[弗朗西斯·克里克|弗朗西斯·克里克]]发现DNA分子具有[[双螺旋结构|双螺旋结构]]。[[斯丹利·温鲍姆|斯丹利·温鲍姆]]的1936年的科幻故事普罗透斯岛（Proteus Island）中探索了直接遗传操作的一般概念。

1972年，[[保罗·伯格|保罗·伯格]]通过将来自猴病毒SV40的DNA与[[λ病毒|λ病毒]]的DNA结合而产生了第一个重组DNA分子。<ref>{{cite journal|doi=10.1073/pnas.69.10.2904|last1=Jackson|title=Biochemical Method for Inserting New Genetic Information into DNA of Simian Virus 40: Circular SV40 DNA Molecules Containing Lambda Phage Genes and the Galactose Operon of Escherichia coli|first1=DA|last2=Symons|first2=RH|last3=Berg|first3=P|first8= David A. Jackson Robert H. Symons and Paul Berg|journal=PNAS|date=1972-10-01|volume=69|issue=10|pages=2904–2909|pmid=4342968|pmc=389671|bibcode = 1972PNAS...69.2904J }}</ref>在1973年，[[赫伯特·博耶|赫伯特·博耶]]和[[斯坦利·科恩|斯坦利·科恩]]通过将[[抗生素|抗生素]]抗性基因插入到[[大肠杆菌|大肠杆菌]]细菌的质粒中而产生了第一个遗传修饰生物。<ref>{{cite web|title=History of Genetics: Genetic Engineering Timeline|last=Arnold|first=Paul|year=2009|url=http://www.brighthub.com/science/genetics/articles/21983.aspx|accessdate=2017-02-08|archive-date=2019-05-24|archive-url=https://web.archive.org/web/20190524051241/https://www.brighthub.com/science/genetics/articles/21983.aspx|dead-url=no}}</ref><ref>{{cite web |first1=Stanley N. |last1=Cohen |first2=Annie C. Y. |last2=Chang |url=http://www.pnas.org/content/70/5/1293.short |title=Recircularization and Autonomous Replication of a Sheared R-Factor DNA Segment in Escherichia coli Transformants — PNAS |publisher=Pnas.org |date=1973-05-01 |accessdate=2010-07-17 |archive-date=2019-05-21 |archive-url=https://web.archive.org/web/20190521010134/https://www.pnas.org/content/70/5/1293.short |dead-url=no }}</ref>一年后，[[鲁道夫·耶尼施|鲁道夫·耶尼施]]通过将外来DNA引入其胚胎中创建了一种遗传修饰小鼠，使其成为世界上第一个遗传修饰动物<ref>Jaenisch, R. and Mintz, B. (1974 ) Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA. Proc. Natl. Acad. 71(4) 1250–1254 [http://www.pnas.org/content/71/4/1250] {{Wayback|url=http://www.pnas.org/content/71/4/1250 |date=20190707123834 }}</ref>这些成就导致了科学界对基因工程的潜在风险的关注，这些问题首先在1975年的[[阿西洛马会议|阿西洛马会议]]上进行了深入讨论。这次会议的主要建议之一是，在技术的安全性得到确认之前政府应加强对重组DNA研究的监督。<ref>{{cite journal | author = Berg P | year = 1975 | title = Summary statement of the Asilomar Conference on recombinant DNA molecules | url = http://www.pnas.org/content/72/6/1981.full.pdf | format = PDF | journal = Proc. Natl. Acad. Sci. U.S.A | volume = 72 | issue = 6 | pages = 1981–4 | doi = 10.1073/pnas.72.6.1981 | pmid = 806076 | last2 = Baltimore | first2 = D | last3 = Brenner | first3 = S | last4 = Roblin | first4 = RO | last5 = Singer | first5 = MF | pmc = 432675 | bibcode = 1975PNAS...72.1981B | display-authors = etal | access-date = 2017-02-08 | archive-date = 2011-07-15 | archive-url = https://web.archive.org/web/20110715113724/http://www.pnas.org/content/72/6/1981.full.pdf }}</ref><ref>{{Cite web |url=http://oba.od.nih.gov/rdna/nih_guidelines_oba.html |title=NIH Guidelines for research involving recombinant DNA molecules |access-date=2017-02-08 |archive-url=https://web.archive.org/web/20120910070047/http://oba.od.nih.gov/rdna/nih_guidelines_oba.html |archive-date=2012-09-10 |dead-url=yes }}{{webarchive |url=https://web.archive.org/web/20120910070047/http://oba.od.nih.gov/rdna/nih_guidelines_oba.html |date=2012-09-10 }}</ref>
1976年，[[赫伯特·博耶|赫伯特·博耶]]和羅伯特·史旺森创立了遗传工程公司[[基因泰克|基因泰克]]（Genentech），该公司在大肠杆菌中生产了人类蛋白[[生长抑素|生长抑素]]。 基因泰克在1978年宣布生产遗传修饰生产的人[[胰岛素|胰岛素]]。<ref>{{cite journal |doi=10.1073/pnas.76.1.106 |last=Goeddel |first=David |first2=Dennis G. |last2=Kleid |first3=Francisco |last3=Bolivar |first4=Herbert L. |last4=Heyneker |first5=Daniel G. |last5=Yansura |first6=Roberto |last6=Crea |first7=Tadaaki |last7=Hirose |first8=Adam |last8=Kraszewski |first9=Keiichi |last9=Itakura |first10=Arthur D. |last10=Riggs |title=Expression in Escherichia coli of chemically synthesized genes for human insulin |journal=PNAS |date=January 1979 |volume=76 |issue=1 |pages=106–110 |url=http://www.pnas.org/content/76/1/106.full.pdf |pmid=85300 |pmc=382885 |bibcode=1979PNAS...76..106G |access-date=2017-02-08 |archive-date=2017-11-15 |archive-url=https://web.archive.org/web/20171115230742/http://www.pnas.org/content/76/1/106.full.pdf |dead-url=no }}</ref>1980年，美国最高法院在Diamond诉Chakrabarty案中裁定，遗传改变的生命可以获得专利。<ref>{{cite journal |url=http://supreme.justia.com/us/447/303/case.html |title=Diamond V Chakrabarty |volume=447 |author=US Supreme Court Cases from Justia & Oyez |publisher=Supreme.justia.com |date=1980-06-16 |accessdate=2010-07-17 |issue=303 |archive-date=2012-01-07 |archive-url=https://web.archive.org/web/20120107012535/http://supreme.justia.com/us/447/303/case.html |dead-url=no }}</ref>此種藉由细菌生產的胰岛素以「[[優泌林|優泌林]]」作為品牌名稱，在1982年經[[美国食品药物监督管理局|美国食品药物监督管理局]]批准销售。<ref>{{cite news |url=http://www.time.com/time/magazine/article/0,9171,949646-1,00.html |title=Artificial Genes |work=TIME |date=1982-11-15 |accessdate=2010-07-17 |archive-date=2013-05-21 |archive-url=https://web.archive.org/web/20130521070027/http://www.time.com/time/magazine/article/0,9171,949646-1,00.html |dead-url=no }}</ref>

[[File:Pseudomonas_syringae_cultures.jpg|缩略图]]

在20世纪70年代，[[威斯康辛大学麦迪逊分校|威斯康辛大学麦迪逊分校]]的研究生史蒂文·林多（Steven Lindow）与D.C.阿尔尼（D.C.Arny）和C.韦瑟（C.Weather）发现了一种细菌，它被认为是在冰成核过程中发挥作用的丁香假单胞菌，并在1977年发现了一种[[突变|突变]]的减冰细菌。 林多博士（现在是加州大学伯克利分校的植物病理学家）后来成功创建了一个重组减冰细菌。<ref>H. Patricia Hynes. (1989) Biotechnology in agriculture: an analysis of selected technologies and policy in the United States.  Reproductive and Genetic Engineering (2)1:39–49 {{cite web |url=http://www.finrrage.org/pdf_files/RepTech%20General/Biotechnology_in_Agriculture.pdf |title=存档副本 |accessdate=2012-09-03 |deadurl=yes |archiveurl=https://web.archive.org/web/20141204183144/http://www.finrrage.org/pdf_files/RepTech%20General/Biotechnology_in_Agriculture.pdf |archivedate=2014-12-04 }}</ref>1983年，一家生物技术公司先进遗传科学公司（Advanced Genetic Sciences，AGS）申请美国政府授权，使用丁香假单胞菌的减冰菌菌株进行田间试验，以保护作物免受[[霜冻|霜冻]]，但[[环境组织|环境组织]]和抗议者通过法律挑战推迟了此项田间试验四年。<ref>{{cite journal | last1 = Bratspies | first1 = Rebecca | year = 2007 | title = Some Thoughts on the American Approach to Regulating Genetically Modified Organisms | url = http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1017832 | format = PDF | journal = Kansas Journal of Law & Public Policy | volume = 16 | issue = 3 | pages = 101–131 | access-date = 2017-02-08 | archive-date = 2022-06-12 | archive-url = https://web.archive.org/web/20220612011102/https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1017832 }}</ref> 1987年，随着加利福尼亚的草莓田和马铃薯田的喷雾，丁香假单胞菌的减冰菌菌株成为第一个被释放到环境中的遗传修饰生物<ref name="BBC2002">BBC News 14 June 2002 [http://news.bbc.co.uk/2/hi/science/nature/2045286.stm GM crops: A bitter harvest?] {{Wayback|url=http://news.bbc.co.uk/2/hi/science/nature/2045286.stm |date=20220419232302 }}</ref>这两块测试田在测试开始前一天晚上都遭到活动家团体攻击：“世界上第一的试验田吸引了世界第一的捣蛋鬼”。<ref name="BBC2002" />

1986年在[[法国|法国]]和[[美国|美国]]进行了遗传修饰植物的第一次田间试验，实验植物为一种抗除草剂的遗传修饰[[烟草|烟草]]。<ref>{{cite web|last=James|first=Clive|title=Global Review of the Field Testing and Commercialization of Transgenic Plants: 1986 to 1995|url=http://www.isaaa.org/kc/Publications/pdfs/isaaabriefs/Briefs%201.pdf|publisher=The International Service for the Acquisition of Agri-biotech Applications|accessdate=2010-07-17|year=1996|archive-date=2019-07-24|archive-url=https://web.archive.org/web/20190724004503/http://www.isaaa.org/kc/Publications/pdfs/isaaabriefs/Briefs%201.pdf|dead-url=no}}</ref>[[中华人民共和国|中华人民共和国]]是第一个将遗传修饰植物商业化的国家，1992年引入了抗病毒的烟草。<ref name="James1997">{{cite journal |last=James |first=Clive |year=1997 |title=Global Status of Transgenic Crops in 1997 |journal=ISAAA Briefs No. 5. |page=31 |url=http://www.isaaa.org/resources/publications/briefs/05/download/isaaa-brief-05-1997.pdf |access-date=2017-02-09 |archive-date=2018-12-22 |archive-url=https://web.archive.org/web/20181222181829/http://www.isaaa.org/resources/publications/briefs/05/download/isaaa-brief-05-1997.pdf |dead-url=no }}</ref> 在1994年，佳基因公司（Calgene）获批将Flavr Savr[[番茄|番茄]]（一种具有较长的保质期的遗传修饰番茄）投入市场，<ref>{{cite journal|doi=10.3733/ca.v054n04p6 |title=The case of the FLAVR SAVR tomato |year=2000 |last1=Bruening |first1=G. |last2=Lyons |first2=J.M. |journal=California Agriculture |volume=54 |issue=4 |pages=6–7}}</ref>同年[[欧盟|欧盟]]批准遗传修饰抗除草剂[[溴苯腈|溴苯腈]]烟草，使其成为在欧洲商业化的第一个遗传修饰作物。<ref>{{cite journal|title=Transgenic tobacco is European first|date=1994-06-18|last=MacKenzie|first=Debora|url=http://www.newscientist.com/article/mg14219301.100-transgenic-tobacco-is-european-first.html|publisher=New Scientist|journal=|access-date=2017-02-09|archive-date=2015-05-21|archive-url=https://web.archive.org/web/20150521011003/http://www.newscientist.com/article/mg14219301.100-transgenic-tobacco-is-european-first.html|dead-url=no}}</ref>1995年，[[马铃薯|马铃薯]]作物Bt Potato在经[[美国食品药品监督管理局|美国食品药品监督管理局]]和[[美国环境保护局|美国环境保护局]]批准安全使用，成为美国第一个批准的抗虫遗传修饰作物。<ref>[https://news.google.com/newspapers?nid=2199&dat=19950506&id=A0YyAAAAIBAJ&sjid=jOYFAAAAIBAJ&pg=4631,1776980&hl=en Genetically Altered Potato Ok'd For Crops] {{Wayback|url=https://news.google.com/newspapers?nid=2199&dat=19950506&id=A0YyAAAAIBAJ&sjid=jOYFAAAAIBAJ&pg=4631,1776980&hl=en |date=20220417160823 }} Lawrence Journal-World - 6 May 1995</ref>

2009年，11个遗传修饰作物在25个国家商业化生产，主要为美国、[[巴西|巴西]]、[[阿根廷|阿根廷]]、[[印度|印度]]、[[加拿大|加拿大]]、[[中华人民共和国|中国]]、[[巴拉圭|巴拉圭]]和[[南非|南非]]。<ref>[http://www.isaaa.org/resources/publications/briefs/41/executivesummary/default.asp Global Status of Commercialized Biotech/GM Crops: 2009] {{Wayback|url=http://www.isaaa.org/resources/publications/briefs/41/executivesummary/default.asp |date=20171008212351 }} ISAAA Brief 41-2009, 23 February 2010. Retrieved 10 August 2010</ref>

2010年，[[克莱格·凡特|克莱格·凡特]]研究所的科学家创建了第一个合成基因组并将其插入空的[[细菌|细菌]]细胞。得到的细菌，名为“[[辛西娅|辛西娅]]”（Synthia），可以复制和产生[[蛋白质|蛋白质]]。<ref>{{Cite journal
| last = Pennisi
| first = Elizabeth
| date = 2010-05-21
| title = Synthetic Genome Brings New Life to Bacterium
| url = http://science.sciencemag.org/content/328/5981/958
| journal = Science
| language = en
| volume = 328
| issue = 5981
| pages = 958–959
| doi = 10.1126/science.328.5981.958
| issn = 0036-8075
| pmid = 20488994
| access-date = 2017-02-09
| archive-date = 2021-08-08
| archive-url = https://web.archive.org/web/20210808104157/https://science.sciencemag.org/content/328/5981/958
}}</ref><ref>{{cite journal |doi=10.1126/science.1190719 |title=Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome |year=2010 |last1=Gibson |first1=D. G. |last2=Glass |first2=J. I. |last3=Lartigue |first3=C. |last4=Noskov |first4=V. N. |last5=Chuang |first5=R.-Y. |last6=Algire |first6=M. A. |last7=Benders |first7=G. A. |last8=Montague |first8=M. G. |last9=Ma |first9=L. |last10=Moodie |first10=M. M. |last11=Merryman |first11=C. |last12=Vashee |first12=S. |last13=Krishnakumar |first13=R. |last14=Assad-Garcia |first14=N. |last15=Andrews-Pfannkoch |first15=C. |last16=Denisova |first16=E. A. |last17=Young |first17=L. |last18=Qi |first18=Z.-Q. |last19=Segall-Shapiro |first19=T. H. |last20=Calvey |first20=C. H. |last21=Parmar |first21=P. P. |last22=Hutchison Ca |first22=C. A. |last23=Smith |first23=H. O. |last24=Venter |first24=J. C. |journal=Science |volume=329 |issue=5987 |pages=52–6 |pmid=20488990}}</ref>在2014年，开发了一种[[细菌|细菌]]，其复制含有独特[[碱基对|碱基对]]（非[[A|腺嘌呤]]、[[C|胞嘧啶]]、[[T|胸腺嘧啶]]、[[G|鸟嘌呤]]）的[[质粒|质粒]]，是首个使用扩展遗传字母表的生物体。<ref>{{Cite journal
| last = Malyshev
| first = Denis A.
| last2 = Dhami
| first2 = Kirandeep
| last3 = Lavergne
| first3 = Thomas
| last4 = Chen
| first4 = Tingjian
| last5 = Dai
| first5 = Nan
| last6 = Foster
| first6 = Jeremy M.
| last7 = Corrêa
| first7 = Ivan R.
| last8 = Romesberg
| first8 = Floyd E.
| date = 2014-05-15
| title = A semi-synthetic organism with an expanded genetic alphabet
| url = http://www.nature.com/nature/journal/v509/n7500/full/nature13314.html
| journal = Nature
| language = en
| volume = 509
| issue = 7500
| pages = 385–388
| doi = 10.1038/nature13314
| issn = 0028-0836
| pmc = 4058825
| pmid = 24805238
| access-date = 2017-02-09
| archive-date = 2020-07-16
| archive-url = https://web.archive.org/web/20200716225931/https://www.nature.com/articles/nature13314
| dead-url = no
}}</ref><ref>{{Cite journal
| last = Thyer
| first = Ross
| last2 = Ellefson
| first2 = Jared
| date = 2014-05-15
| title = Synthetic biology: New letters for life's alphabet
| url = http://www.nature.com/nature/journal/v509/n7500/full/nature13335.html
| journal = Nature
| language = en
| volume = 509
| issue = 7500
| pages = 291–292
| doi = 10.1038/nature13335
| issn = 0028-0836
}}</ref>

== 操作与步驟 ==
[[File:Btcornafrica.jpg|thumb]]人在檢查經過具有抗蟲害基因轉移的玉米]]
如果將一種[[生物|生物]]的[[DNA|DNA]]中的某個[[遺傳密碼|遺傳密碼]]片段連接到另外一種生物的DNA鏈上去，將DNA重新組織一下，就可以按照[[人類|人類]]的願望，設計出新的遺傳物質並創造出新的生物類型，這基因工程一般包括以下四個步驟：
# 取得符合要求的DNA片段；
# 构建基因的表达载体；
# 將目的基因导入受体细胞；
# 目的基因的检测与鉴定。

=== 取得符合要求的DNA片段 ===

第一步是选择并分离将被插入到遗传修饰的生物体中的基因。要把目的基因从供体DNA长链准确地剪切下来，可不是一件容易的事。1968年，[[沃纳·阿尔伯|沃纳·阿尔伯]]、[[丹尼尔·内森斯|丹尼尔·内森斯]]和[[漢彌爾頓·史密斯|漢彌爾頓·史密斯]]第一次从[[大肠杆菌|大肠杆菌]]中提取出了[[限制酶|限制性核酸内切酶]]，它能够在DNA上寻找特定的“切点”，认准后将DNA分子的双链交错地切断。<ref name="pmid4897066">{{cite journal | vauthors = Arber W, Linn S | title = DNA modification and restriction | url = https://archive.org/details/sim_annual-review-of-biochemistry_1969_38/page/467 | journal = Annual Review of Biochemistry | volume = 38 | issue =  | pages = 467–500 | year = 1969 | pmid = 4897066 | doi = 10.1146/annurev.bi.38.070169.002343 }}</ref>人们把这种限制性内切酶称为“分子剪刀”。这种“分子剪刀”可以完整地切下个别基因。自1970年代以来，人们已经分离提取了400多种“分子剪刀”。<ref name=":0">{{Cite book|title=高等职业教育生物技术类专业系列教材·基因工程技术|last=曾|first=佑炜|authorlink=|last2=揭|first2=广川|authorlink2=|last3=李|first3=家洲|publisher=中国轻工业出版社|year=2010|isbn=9787501975785|location=|pages=}}</ref>有了形形色色的“分子剪刀”，人们就可以随心所欲地进行DNA分子长链的切割了。可以使用限制酶分离基因以将DNA切割成片段并进行凝胶电泳，以根据长度将它们分离出来。<ref>{{cite book|vauthors=Alberts B, Johnson A, Lewis J, etal|title=Isolating, Cloning, and Sequencing DNA.|edition=4th|location=New York|publisher=Garland Science|year=2002|url=http://www.ncbi.nlm.nih.gov/books/NBK26837/|chapter=8|access-date=2017-02-09|archive-date=2022-04-14|archive-url=https://web.archive.org/web/20220414065722/https://www.ncbi.nlm.nih.gov/books/NBK26837/}}</ref>聚合酶链反应（PCR）也可以用于扩增基因区段，然后可以通过凝胶电泳分离。<ref>{{cite journal|journal=J Bacteriol|year=1996 |volume=178|pages=3967–3970|title=Use of PCR to isolate genes encoding sigma54-dependent activators from diverse bacteria|url=https://archive.org/details/sim_journal-of-bacteriology_1996-07_178_13/page/3967|first=R I |last=Kaufman |first2=B T |last2=Nixon|issue=13|pmid=8682806|pmc=232662 |doi=10.1128/jb.178.13.3967-3970.1996}}</ref> 如果所选择的基因或供体生物体的基因组已经被充分研究，它可以存在于基因库中。如果DNA序列已知，但没有该基因的拷贝可用，则可以人工合成。<ref>{{cite journal |doi=10.1002/wsbm.104 |title=Synthetic biology: Putting synthesis into biology |year=2011 |last1=Liang |first1=Jing |last2=Luo |first2=Yunzi |last3=Zhao |first3=Huimin |journal=Wiley Interdisciplinary Reviews: Systems Biology and Medicine |volume=3 |pages=7–20}}</ref>

要插入遗传修饰的生物体中的基因必须与其它遗传元件组合以使其正常工作。还可以在该阶段修饰基因以更好地表达或有效性。除了要插入的基因之外，大多数构建体含有启动子和终止子区以及选择标记基因。启动子区启动基因的转录，并且可以用于控制基因表达的位置和水平，而终止子区终止转录。<ref name="#1">{{cite journal |doi=10.1534/genetics.109.112144 |title=Personal Reflections on the Origins and Emergence of Recombinant DNA Technology |year=2010 |last1=Berg |first1=P. |last2=Mertz |first2=J. E. |journal=Genetics |volume=184 |pages=9–17 |pmid=20061565 |issue=1 |pmc=2815933}}</ref> 在大多数情况下赋予其在其中表达的生物体抗生素抗性的选择性标记，需要确定哪些细胞用新基因转化。

=== 构建基因表达载体 ===

DNA的分子链被切开后，还得缝接起来以完成基因的拼接。1967年，科学家们在5个实验室里几乎同时发现并提取出一种[[酶|酶]]，这种酶可以将两个DNA片段连接起来，修复好DNA链的断裂口。<ref name="WeissRichardson1967">{{cite journal | vauthors = Weiss B, Richardson CC | title = Enzymatic breakage and joining of deoxyribonucleic acid, I. Repair of single-strand breaks in DNA by an enzyme system from Escherichia coli infected with T4 bacteriophage | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 57 | issue = 4 | pages = 1021–8 |date=April 1967 | pmid = 5340583 | pmc = 224649 | doi =10.1073/pnas.57.4.1021 }}</ref>1974年以后科学界正式肯定了这一发现，并把这种酶叫作[[DNA連接酶|DNA连接酶]]。<ref name=":0" />从此，DNA连接酶就成了名符其实的“缝合”基因的“分子针线”。只要在用同一种“分子剪刀”剪切的两种DNA碎片中加上“分子针线”，就会把两种DNA片段重新连接起来。

==== 质粒载体 ====
DNA的操作通常发生在[[质粒|质粒]]内。使用[[重组DNA|重组DNA]]技术，例如限制性消化，连接和分子克隆制备构建体。<ref name="#1"/>  其中一种常见的技术是将新的遗传物质插入宿主基因组中的特定位置，或在所需的能够敲除的基因组位点产生[[突变|突变]]内源基因。基因靶向技术使用同源重组来靶向特定内源基因的期望变化。这在植物和动物中发生的频率相对较低，并且通常需要使用选择标记基因。使用工程化[[核酸酶|核酸酶]]如[[锌指核酸酶|锌指核酸酶]]，<ref>{{cite journal  |vauthors=Townsend JA, Wright DA, Winfrey RJ, etal |title=High-frequency modification of plant genes using engineered zinc-finger nucleases |journal=Nature |volume=459 |issue=7245 |pages=442–5 |date=May 2009 |pmid=19404258 |pmc=2743854 |doi=10.1038/nature07845 |url= |bibcode=2009Natur.459..442T}}</ref><ref>{{cite journal

 |vauthors=Shukla VK, Doyon Y, Miller JC, etal |title=Precise genome modification in the crop species Zea mays using zinc-finger nucleases

|journal=Nature

|volume=459

|issue=7245

|pages=437–41

|date=May 2009

|pmid=19404259

|doi=10.1038/nature07992

|bibcode=2009Natur.459..437S

}}</ref>工程改造的归巢核酸内切酶（或“兆碱基”）<ref>{{cite journal  |vauthors=Grizot S, Smith J, Daboussi F, etal |title=Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease |journal=Nucleic Acids Res. |volume=37 |issue=16 |pages=5405–19 |date=September 2009 |pmid=19584299 |pmc=2760784 |doi=10.1093/nar/gkp548 |url=}}</ref><ref>{{cite journal  |vauthors=Gao H, Smith J, Yang M, etal |title=Heritable targeted mutagenesis in maize using a designed endonuclease |journal=Plant J. |volume=61 |issue=1 |pages=176–87 |date=January 2010 |pmid=19811621 |doi=10.1111/j.1365-313X.2009.04041.x |url=}}</ref>或由TAL效应物产生的核酸酶，<ref>{{cite journal  |vauthors=Christian M, Cermak T, Doyle EL, etal |title=TAL Effector Nucleases Create Targeted DNA Double-strand Breaks |journal=Genetics |volume= 186|issue= 2|pages= 757–61|date=July 2010 |pmid=20660643 |pmc=2942870 |doi=10.1534/genetics.110.120717 |url=}}</ref><ref>{{cite journal  |vauthors=Li T, Huang S, Jiang WZ, etal |title=TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain |journal=Nucleic Acids Res |volume= 39|issue= 1|pages= 359–72|date=August 2010 |pmid=20699274 |pmc=3017587 |doi=10.1093/nar/gkq704 |url=}}</ref>可以增强基因靶向的频率。
除了增强基因靶向，工程化核酸酶也可以用于在产生基因敲除的内源基因中引入突变。<ref>{{cite journal

|first = S.C.

|last=Ekker

|year=2008

|title=Zinc finger-based knockout punches for zebrafish genes

|journal=Zebrafish

|volume=5

|pages=1121–3

|doi = 10.1089/zeb.2008.9988

|pmid = 18554175

|issue = 2

|pmc = 2849655

}}</ref><ref>{{cite journal

 |vauthors=Geurts AM, Cost GJ, Freyvert Y, etal |title=Knockout rats via embryo microinjection of zinc-finger nucleases

|journal=Science

|volume=325

|issue=5939

|page=433

|date=July 2009

|pmid=19628861

|doi=10.1126/science.1172447

|pmc=2831805

|bibcode = 2009Sci...325..433G }}</ref>

==== 病毒载体 ====
{{主条目|病毒載體}}
病毒载体是一种常用的工具，可将[[遺傳物質|遗传物质]]带入[[細胞|细胞]]。可发生于完整活体或是[[細胞培養|细胞培养]]中。原理是利用病毒具有传送其[[基因組|基因组]]进入其他细胞，进行感染的分子机制。<ref name=":1">{{Cite journal|title=Construction of hybrid viruses containing SV40 and λ phage DNA segments and their propagation in cultured monkey cells|last2=Berg|first2=P.|journal=Cell|issue=4|doi=10.1016/0092-8674(76)90133-1|year=1976|volume=9|pages=695–705|pmc=|pmid=189942|last1=Goff|first1=S.}}</ref>

慢病毒载体是病毒载体中的一种在[[慢病毒屬|慢病毒]]基础上发展起来的基因工程载体。慢病毒基因组不需要靶细胞分裂即可整合到细胞核中。来源于慢病毒的载体也体现了能够稳定地转导分裂和非分裂细胞（包括干细胞）这一优势。<ref>{{Cite journal|title=Lentiviruses as gene transfer agents for delivery to non-dividing cells.|author=Naldini L.|url=|journal=Curr Opin Biotechnol.|issue=9|doi=10.1016/S0958-1669(98)80029-3|others=|year=1989|volume=|page=|pmid=9821272}}</ref>慢病毒载体目前已发展成为一个强大的基因转移工具，广泛应用于生物学研究和基因治疗。慢病毒载体构建时，病毒的顺式作用元件（非编码所需的转录、反转录和包装元素）必须与反式作用元件（酶、结构和辅助蛋白编码）序列分离，以防止形成具有复制能力的慢病毒颗粒（RCL）。<ref>{{Cite journal|title=Application of lentiviral vectors in genetic engineering|author=戴胜兰，汤正好，臧国庆|url=|journal=International Journal of Epidemiology and Infectious Disease|issue=|doi=|others=|year=|volume=|page=|pmid=}}</ref>

=== 将目的基因导入受体细胞 ===
{{main article|转化 (生物)}}

只有约1％的细菌天然能够摄取外源DNA。然而，这种能力可以通过外部刺激（例如热或电击）诱导其他细菌产生，增加其[[细胞膜|细胞膜]]对DNA的[[通透性|通透性]]；已吸收的DNA可以与基因组整合或作为染色体外DNA（如[[质粒|质粒]]）存在。 DNA通常使用[[显微注射|显微注射]]插入动物细胞，其中它可以通过细胞的[[核膜|核膜]]直接注射到细胞核中或通过使用病毒载体。<ref>{{cite journal |last=Chen |first=I |last2=Dubnau |first2=D |title=DNA uptake during bacterial transformation |journal=Nat. Rev. Microbiol. |volume=2 |issue=3 |pages=241–9 |year=2004 |pmid=15083159 |doi=10.1038/nrmicro844}}</ref>在植物中，通常使用[[农杆菌|农杆菌]]介导的[[重组DNA|重组]]或[[基因枪|基因枪]]技术（biolistics）插入DNA。<ref>{{cite book |first=Graham |last=Head |last2=Hull |first2=Roger H |last3=Tzotzos |first3=George T. |title=Genetically Modified Plants: Assessing Safety and Managing Risk |url=https://archive.org/details/geneticallymodif00hull |publisher=Academic Pr |location=London |year=2009 |page=[https://archive.org/details/geneticallymodif00hull/page/n254 244] |isbn=0-12-374106-8 |oclc= |doi= |accessdate=}}</ref>

在农杆菌介导的重组中，质粒构建体含有T-DNA，其负责将DNA插入宿主植物基因组中。在感染植物细胞之前，将该质粒转化到不含质粒的农杆菌中。然后农杆菌将天然地将遗传物质插入植物细胞中。<ref>{{cite journal |doi=10.1128/MMBR.67.1.16-37.2003 |title=Agrobacterium-Mediated Plant Transformation: The Biology behind the "Gene-Jockeying" Tool |url=https://archive.org/details/sim_microbiology-and-molecular-biology-reviews_2003-03_67_1/page/16 |year=2003 |last1=Gelvin |first1=S. B. |journal=Microbiology and Molecular Biology Reviews |volume=67 |pages=16–37, table of contents |pmid=12626681 |issue=1 |pmc=150518}}</ref>在生物动力学中，[[金|金]]或[[钨|钨]]的颗粒用DNA包被，然后注射到[[愈伤组织|愈伤组织]]细胞或植物胚胎中。一些遗传物质将进入细胞并转化它们。该方法可以用于不易受农杆菌感染的植物上，并且还允许植物[[色素体|质体]]的转化。用于植物和动物细胞的另一种转化方法是电穿孔。电穿孔包括使植物或动物细胞遭受电击，其可使细胞膜对质粒DNA可透过，在一些情况下，电穿孔细胞可将DNA掺入其基因组中。由于其对细胞和DNA的损害，[[基因枪|基因枪]]和电穿孔的转化效率低于农杆菌介导的转化和[[显微注射|显微注射]]。<ref>{{cite web |title=DNA-Delivery Methods to Produce Transgenic Plants |first=Behrooz |last=Darbani |first2=Safar |last2=Farajnia |first3=Mahmoud |last3=Toorchi |first4=Saeed |last4=Zakerbostanabad |first5=Shahin |last5=Noeparvar |first6=C. Neal |last6=Stewart, Jr. |year=2010 |publisher=Science Alert |url=http://scialert.net/fulltext/?doi=biotech.2008.385.402 |accessdate= |archive-date=2019-05-24 |archive-url=https://web.archive.org/web/20190524040400/https://scialert.net/fulltext/?doi=biotech.2008.385.402 |dead-url=no }}</ref>

由于用于转化的细胞通常只有一个，因此必须将该单个细胞培育成生物体。细菌由单个细胞组成并且不需要[[克隆|克隆]]再生。在植物中，这通过使用[[組織培養|组织培养]]来实现。每种植物对通过组织培养成功再生具有不同的要求。如果成功，则产生在每个细胞中含有遗传修饰的成年植物。在动物中，有必要确保插入的DNA存在于[[胚胎干细胞|胚胎干细胞]]中。

=== 目的基因的检测与鉴定 ===
[[File:Gel_Doc_with_PC.JPG|thumb]]

选择标记用于区分转化的和未转化的细胞。这些标记通常存在于遗传修饰生物体中，尽管已经开发了可以从成熟遗传修饰植物中除去选择性标记的多种策略。<ref>{{cite journal |doi=10.1016/S0958-1669(00)00188-9 |title=Elimination of selection markers from transgenic plants |year=2001 |last1=Hohn |first1=Barbara |last2=Levy |first2=Avraham A |last3=Puchta |first3=Holger |journal=Current Opinion in Biotechnology |volume=12 |issue=2 |pages=139–43 |pmid=11287227}}</ref> 当产生后代时，可以筛选基因的存在。来自第一代的所有后代对于插入的基因将是杂合的，并且必须交配在一起以产生纯合动物。

进一步的测试使用[[聚合酶链反应|PCR]]，[[南方墨点法|南方墨点法]]（Southern印迹），并且进行DNA测序以确认生物体含有新基因。即将遗传修饰生物的基因组DNA提取出来，在含有目的基因的DNA片段上用放射性同位素等做标记，以此作为探针，使探针与基因组DNA杂交，如果显示出杂交带，就表明目的基因已插入染色体DNA中。该方法因发现者而命名为南方墨点法。这些测试还可以确认插入基因的染色体位置和拷贝数。基因的存在并不保证其在靶组织中以适当的水平表达，因此也使用寻找和测量基因产物（RNA和蛋白质）的方法。这些包括[[北方墨点法|北方墨点法]]（Northern印迹），定量[[即時聚合酶鏈式反應|即時聚合酶鏈鎖反應]]（RT-PCR），[[西方墨点法|西方墨点法]]，免疫荧光，[[酶联免疫吸附试验|酵素免疫分析法]]（ELISA）和[[表型|表型]]分析。为了稳定转化，该基因应以[[孟德尔|孟德尔]]遗传模式传递给后代，因此也应研究该生物的子代。

== 应用及成果 ==

基因工程在医学、研究、工业和农业中的都有所应用，并且可以广泛应用于植物、动物和微生物。

===医学===

在医学中，基因工程已经用于制造药物，创建模型动物，进行实验室研究和[[基因治疗|基因治疗]]。

====生产====

遗传工程用于大规模生产[[胰岛素|胰岛素]]、[[生长激素|生长激素]]、follistim（用于治疗不育）、人[[白蛋白|白蛋白]]、[[单克隆抗体|单克隆抗体]]、[[凝血因子|凝血因子]]、[[疫苗|疫苗]]和许多其他药物。<ref>{{cite book|title=The hope, hype & reality of genetic engineering: remarkable stories from agriculture, industry, medicine, and the environment|first=John C. |last= Avise|publisher=Oxford University Press US|year=2004|page=22|url={{google books |plainurl=y |id=gR8cWf2-UY4C}}|isbn=978-0-19-516950-8}}</ref><ref>{{cite journal |url=http://phys.org/news/2012-12-algae-complex-anti-cancer-drug.html |title=Engineering algae to make complex anti-cancer 'designer' drug |publisher=PhysOrg |date=2012-12-10 |accessdate=2013-04-15 |journal= |archive-date=2022-04-14 |archive-url=https://web.archive.org/web/20220414065735/https://phys.org/news/2012-12-algae-complex-anti-cancer-drug.html }}</ref>小鼠杂交瘤，融合在一起以产生单克隆抗体的细胞已经通过基因工程人源化以产生人单克隆抗体。正在开发遗传工程改造的[[病毒|病毒]]，其仍然可以赋予免疫性，但缺乏感染序列。<ref>{{cite journal |doi=10.1016/j.vaccine.2009.08.039 |title=Foot and mouth disease virus vaccines |year=2009 |last1=Rodriguez |first1=Luis L. |last2=Grubman |first2=Marvin J. |journal=Vaccine |volume=27 |pages=D90–4 |pmid=19837296}}</ref>

====研究====

基因工程用于创建人类疾病的动物模型。遗传修饰[[小鼠|小鼠]]是最常见的基因工程动物模型。<ref>{{cite web|title=Background: Cloned and Genetically Modified Animals|date=2005-04-14|publisher=Center for Genetics and Society|url=http://www.geneticsandsociety.org/article.php?id=386|access-date=2017-02-09|archive-url=https://web.archive.org/web/20161123110939/http://geneticsandsociety.org/article.php?id=386|archive-date=2016-11-23|dead-url=yes}}</ref>它们已用於[[癌症|癌症]]、[[肥胖|肥胖]]、[[心脏病|心脏病]]、[[糖尿病|糖尿病]]、[[关节炎|关节炎]]、[[药物成瘾|药物成瘾]]、焦虑、[[衰老|衰老]]、[[帕金森病|帕金森病]]的研究和模拟。<ref>{{cite web|title=Knockout Mice|publisher=Nation Human Genome Research Institute|year=2009|url=http://www.genome.gov/12514551|accessdate=2017-02-09|archive-date=2018-12-16|archive-url=https://web.archive.org/web/20181216073853/https://www.genome.gov/12514551/|dead-url=no}}</ref>可以针对这些小鼠模型测试潜在的疗法。在增加器官移植成功率方面，培育了遗传修饰猪。<ref name="Medical News Today">{{cite web|title=GM pigs best bet for organ transplant|publisher=Medical News Today|date=2003-09-21|url=http://www.medicalnewstoday.com/articles/4344.php|accessdate=2017-02-09|archive-date=2011-05-10|archive-url=https://web.archive.org/web/20110510121726/http://www.medicalnewstoday.com/articles/4344.php|dead-url=no}}</ref>

====基因治疗====
{{main article|基因治疗}}

基因治疗是人类的遗传工程，通常通过用有效基因替代有缺陷的基因。这可以发生在体细胞组织或[[种系组织|种系组织]]中。

=====体细胞基因治疗=====

体细胞基因治疗已针对多种疾病进行了[[臨床研究|临床研究]]，包括[[伴性遗传|X连锁]][[嚴重複合型免疫缺乏症|严重复合型免疫缺乏症]]<ref>{{cite journal |doi=10.1038/ni0610-457 |title=20 years of gene therapy for SCID |year=2010 |last1=Fischer |first1=Alain |last2=Hacein-Bey-Abina |first2=Salima |last3=Cavazzana-Calvo |first3=Marina |journal=Nature Immunology |volume=11 |issue=6 |pages=457–60 |pmid=20485269}}</ref>，慢性淋巴细胞性[[白血病|白血病]]（CLL）<ref name = "Porter">{{cite journal |doi=10.1038/news.2011.472 |title=Cell therapy fights leukaemia |year=2011 |last1=Ledford |first1=Heidi |journal=Nature }}</ref>，和帕金森病<ref>{{cite journal |doi=10.1016/S1474-4422(11)70039-4 |title=AAV2-GAD gene therapy for advanced Parkinson's disease: A double-blind, sham-surgery controlled, randomised trial |year=2011 |last1=Lewitt |first1=Peter A |last2=Rezai |first2=Ali R |last3=Leehey |first3=Maureen A |last4=Ojemann |first4=Steven G |last5=Flaherty |first5=Alice W |last6=Eskandar |first6=Emad N |last7=Kostyk |first7=Sandra K |last8=Thomas |first8=Karen |last9=Sarkar |first9=Atom |last10=Siddiqui |first10=Mustafa S |last11=Tatter |first11=Stephen B |last12=Schwalb |first12=Jason M |last13=Poston |first13=Kathleen L |last14=Henderson |first14=Jaimie M |last15=Kurlan |first15=Roger M |last16=Richard |first16=Irene H |last17=Van Meter |first17=Lori |last18=Sapan |first18=Christine V |last19=During |first19=Matthew J |last20=Kaplitt |first20=Michael G |last21=Feigin |first21=Andrew |journal=The Lancet Neurology |volume=10 |issue=4 |pages=309–19 |pmid=21419704}}</ref>  2012年，Glybera成为第一个得到欧洲或美国批准，可在欧洲委员会批准后獲准用于临床使用的基因治疗药物。<ref name=Gallagher>Gallagher, James. (2 November 2012) [http://www.bbc.co.uk/news/health-20179561 BBC News – Gene therapy: Glybera approved by European Commission] {{Wayback|url=http://www.bbc.co.uk/news/health-20179561 |date=20210214002428 }}. Bbc.co.uk. Retrieved on 15 December 2012.</ref><ref name=Richards2012>{{cite web|last=Richards|first=Sabrina|title=Gene Therapy Arrives in Europe|url=http://www.the-scientist.com/?articles.view/articleNo/33166/title/Gene-Therapy-Arrives-in-Europe/|publisher=The Scientist|accessdate=2012-11-16|archive-date=2012-11-18|archive-url=https://web.archive.org/web/20121118211041/http://www.the-scientist.com/?articles.view%2FarticleNo%2F33166%2Ftitle%2FGene-Therapy-Arrives-in-Europe%2F|dead-url=no}}</ref>

=====种系基因治疗=====

关于[[种系|种系]]基因治疗，科学界一直反对使用生物技术以可遗传的方式改变人类基因的尝试，因为该技术才刚刚起步。<ref>{{Cite web|url=http://www.cioms.ch/frame_1990_texts_of_guidelines.htm|title=1990 The Declaration of Inuyama|accessdate=2017-02-10|date=2001-08-05|deadurl=yes|archiveurl=https://web.archive.org/web/20010805085535/http://www.cioms.ch/frame_1990_texts_of_guidelines.htm|archivedate=2001-08-05}}</ref>随着技术的发展、[[CRISPR|CRISPR]]等新技术的出现，<ref>Smith KR, Chan S, Harris J. Human germline genetic modification: scientific and bioethical perspectives. Arch Med Res. 2012 Oct;43(7):491-513. doi: 10.1016/j.arcmed.2012.09.003. PMID 23072719</ref>2015年3月，科学家们敦促世界范围内禁止临床使用[[基因编辑技术|基因编辑技术]]以可遗传的方式编辑人类基因组。<ref name="NYT-20150319">{{cite news |last=Wade |first=Nicholas |title=Scientists Seek Ban on Method of Editing the Human Genome |url=http://www.nytimes.com/2015/03/20/science/biologists-call-for-halt-to-gene-editing-technique-in-humans.html |date=2015-03-19 |work=[[纽约时报|纽约时报]] |accessdate=2015-03-20 |archive-date=2022-05-26 |archive-url=https://web.archive.org/web/20220526075936/https://www.nytimes.com/2015/03/20/science/biologists-call-for-halt-to-gene-editing-technique-in-humans.html }}</ref><ref name="NYT-20150303-AP">{{cite news |last=Pollack |first=Andrew |title=A Powerful New Way to Edit DNA |url=http://www.nytimes.com/2014/03/04/health/a-powerful-new-way-to-edit-dna.html |date=2015-03-03 |work=[[纽约时报|纽约时报]] |accessdate=2015-03-20 |archive-date=2020-12-13 |archive-url=https://web.archive.org/web/20201213222658/https://www.nytimes.com/2014/03/04/health/a-powerful-new-way-to-edit-dna.html |dead-url=no }}</ref><ref name="SCI-20150319">{{cite journal |last1=Baltimore |first1=David |last2=Berg |first2=Paul |last3=Botchan |first3=Dana |last4=Charo |first4=R. Alta |last5=Church |first5=George |last6=Corn |first6=Jacob E. |last7=Daley |first7=George Q. |last8=Doudna |first8=Jennifer A. |last9=Fenner |first9=Marsha |last10=Greely |first10=Henry T. |last11=Jinek |first11=Martin |last12=Martin |first12=G. Steven |last13=Penhoet |first13=Edward |last14=Puck |first14=Jennifer |last15=Sternberg |first15=Samuel H. |last16=Weissman |first16=Jonathan S. |last17=Yamamoto |first17=Keith R. |title=A prudent path forward for genomic engineering and germline gene modification |url=http://www.sciencemag.org/content/early/2015/03/18/science.aab1028 |date=2015-03-19 |journal=[[科学_(期刊)|科学 (期刊)]] |doi=10.1126/science.aab1028 |accessdate=2015-03-20 |pmid=25791083 |volume=348 |pages=36–8 |pmc=4394183 |archive-date=2015-03-28 |archive-url=https://web.archive.org/web/20150328021516/http://www.sciencemag.org/content/early/2015/03/18/science.aab1028 |dead-url=no }}</ref><ref name="NAT-20150312">{{cite journal |last1=Lanphier |first1=Edward |last2=Urnov |first2=Fyodor |last3=Haecker |first3=Sarah Ehlen |last4=Werner |first4=Michael |last5=Smolenski |first5=Joanna |title=Don’t edit the human germ line |url=http://www.nature.com/news/don-t-edit-the-human-germ-line-1.17111 |date=2015-03-26 |journal=[[自然_(期刊)|自然 (期刊)]] |volume=519 |pages=410–411 |doi=10.1038/519410a |accessdate=2015-03-20 |pmid=25810189 |archive-date=2015-03-22 |archive-url=https://web.archive.org/web/20150322215343/http://www.nature.com/news/don-t-edit-the-human-germ-line-1.17111 |dead-url=no }}</ref>2015年4月，中国研究人员报告了基础研究实验的结果引发了争议，在这些实验中，他们使用CRISPR编辑了不可发育的人类[[胚胎|胚胎]]的DNA <ref name="NYT-20150423">{{cite news |last=Kolata |first=Gina |title=Chinese Scientists Edit Genes of Human Embryos, Raising Concerns |url=http://www.nytimes.com/2015/04/24/health/chinese-scientists-edit-genes-of-human-embryos-raising-concerns.html |date=2015-04-23 |work=[[纽约时报|纽约时报]] |accessdate=2015-04-24 |archive-date=2020-12-14 |archive-url=https://web.archive.org/web/20201214035459/https://www.nytimes.com/2015/04/24/health/chinese-scientists-edit-genes-of-human-embryos-raising-concerns.html |dead-url=no }}</ref><ref name="PC-20150418">{{cite journal |last=Liang |first=Puping |title=CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes |url=http://link.springer.com/article/10.1007/s13238-015-0153-5/fulltext.html |date=2015-04-18 |journal={{tsl|en|Protein & Cell||Protein & Cell}} |doi=10.1007/s13238-015-0153-5 |accessdate=2015-04-24 |display-authors=etal |pmid=25894090 |pmc=4417674 |volume=6 |pages=363–72 |archive-date=2017-11-15 |archive-url=https://web.archive.org/web/20171115070115/https://link.springer.com/article/10.1007/s13238-015-0153-5/fulltext.html |dead-url=no }}</ref> 2015年12月，世界主要科学院的科学家们呼吁暂停进行可遗传的[[人类基因组|人类基因组]]编辑，包括与CRISPR-Cas9技术相关的那些。<ref name="NYT-20151203-nw">{{cite news |last=Wade |first=Nicholas |authorlink=Nicholas Wade |title=Scientists Place Moratorium on Edits to Human Genome That Could Be Inherited |url=http://www.nytimes.com/2015/12/04/science/crispr-cas9-human-genome-editing-moratorium.html |date=2015-12-03 |work=[[纽约时报|纽约时报]] |accessdate=2015-12-03 |archive-date=2021-01-12 |archive-url=https://web.archive.org/web/20210112051902/https://www.nytimes.com/2015/12/04/science/crispr-cas9-human-genome-editing-moratorium.html |dead-url=no }}</ref>

如果技术不仅用于治疗，而且用于增强、修改或改变人的外表、适应性、[[智力|智力]]、[[性格|性格]]或[[行为|行为]]，也存在[[伦理|伦理]]问题。<ref>{{cite web|title=The Ethics of Gene Therapy|first=Emilie R.|last=Bergeson|year=1997|url=http://www.ndsu.edu/pubweb/~mcclean/plsc431/students/bergeson.htm|accessdate=2017-02-10|archive-date=2018-06-15|archive-url=https://web.archive.org/web/20180615004409/https://www.ndsu.edu/pubweb/~mcclean/plsc431/students/bergeson.htm|dead-url=no}}</ref>固化和强化之间的区别也很难界定。<ref>{{cite web|first=Kathi E.|last=Hanna|url=http://www.genome.gov/10004767|publisher=National Human Genome Research Institute|title=Genetic Enhancement|accessdate=2017-02-10|archive-date=2017-04-10|archive-url=https://web.archive.org/web/20170410021239/https://www.genome.gov/10004767/|dead-url=no}}</ref> [[超人主义者|超人主义者]]认为人类的增强是可取的。

===科研===
[[File:PCWmice1.jpg|thumb]]

[[File:Expression_of_Human_Wild-Type_and_P239S_Mutant_Palladin.png|thumb]]
遗传工程是科学家的重要工具。来自各种生物的基因和其他遗传信息转化为细菌，以供储存和修饰，遗传修饰的细菌在该过程中产生。使用细菌的原因是其廉价易得，生长、[[克隆|克隆]]繁殖迅速，相对容易转化，而且可以长期保存，在-80℃几乎可以无限期储存。分离後的基因可以储存在细菌中，可无限增殖供给研究。

可以将生物体遗传工程化以发现某些基因的功能。这可能是对[[表现型|生物表型]]的影响，其中表达基因或与其相互作用的其它基因。这些实验通常涉及功能丧失，功能获得，跟踪和表达。

====功能缺失实验====
例如在[[基因敲除|基因敲除]]实验中，遗传修饰生物会缺少一个或多个基因的活性。敲除实验涉及体外构建和操作DNA构建体，其在简单敲除中由所需基因的拷贝组成，或将其改变为无功能的。胚胎干细胞掺入改变的基因、替换已经存在的功能性拷贝。将这些干细胞注射到胚泡中，植入以替代[[亲代|亲代]]遗传物质。实验者藉此分析由该[[突变|突变]]引起的缺陷，从而确定特定基因的作用。这项操作在[[发育生物学|发育生物学]]中使用频繁。在[[黑腹果蝇|黑腹果蝇]]等生物体中另一种可行的方法是在大群体中诱导突变，然后筛选后代以获得所需的突变。类似的方法可以用于植物和原核生物中。功能丧失可说明某种蛋白质是否是某项功能所必需的，而非说明某种蛋白质具有某项功能。特别是如果功能需要多个蛋白质，那么只要缺少其中一个就会丧失这项功能。<ref>{{tsl|en|Ralf Reski||Ralf Reski}} (1998): Physcomitrella and Arabidopsis: the David and Goliath of reverse genetics. Trends Plant in Science 3, 209-210</ref>

====基因导入实验====
与敲除实验的思路相对。这些有时与敲除实验一起进行以更精细地了解所需基因的功能。该过程与敲除工程中的操作大体相同，除了將构建体设计成可增加基因的功能，通常通过提供额外的基因拷贝或更频繁地诱导蛋白质的合成。基因导入用于判断蛋白质是否足够用于功能，但并不总是意味着它是必需的，特别是当处理遗传或功能冗余时。

====基因靶向实验====
寻求获得特定蛋白质的位置和相互作用的信息。一种实现方法是用“融合”基因替换野生型基因，该融合基因是野生型基因与标记基因如绿色荧光蛋白（GFP）的并置，这使得产物的遗传修饰可见。虽然这是一个有用的技术，但是其操作可能破坏基因的功能，产生二次效应，可能会产生可疑的实验结果。更复杂的技术现在正在开发中，用以跟踪蛋白质产物而不减轻其功能，例如添加将作为[[单克隆抗体|单克隆抗体]]的结合基序的小序列。<ref>{{en}}{{cite journal|title=Yeast: an experimental organism for modern biology|author=Botstein D, Fink GR|journal=Science|issue=4858|year=1988|volume=240|pages=1439-1443|pmid=3287619}}</ref>
====表达实验====
表达实验旨在发现特定蛋白质在何处和何时产生。在这些实验中，将编码蛋白质的DNA（称为基因的启动子）之前的DNA序列重新引入生物体中，其中蛋白质编码区由报告基因（例如GFP）或催化染料产生的酶所取代。<ref>Kamvysselis, M. (2003). ''Computational molecular genomics: genes, regulation, evolution''. (Doctoral Dissertation). Retrieved from http://web.mit.edu/manoli/www/thesis/Intro.html {{Wayback|url=http://web.mit.edu/manoli/www/thesis/Intro.html |date=20210808095058 }}</ref>因此，可以观察到产生特定蛋白质的时间和地点。表达研究可以进一步通过改变[[启动子|启动子]]来发现哪些片段对于基因的正确表达至关重要，且实际上由转录因子蛋白结合；这个过程称为{{tsl|en|Promoter bashing||启动子敲击}}。<ref>Chalfie, M., & Kain, S. (2005) ''Methods of Biological Analyses, Green Fluorescent Protein: Properties, Applications, and Protocols''. Wiley.</ref><ref>Matsukura, S., Stellato, C., Plitt, J. R., Bickel, C., Miura, K., Georas, S. N., Casolaro, V., Schleimer, R. P. (1999). "Activation of Eotaxin Gene Transcription by NF-κB and STAT6 in Human Airway Epithelial Cells". ''J Immunol'' 163:6876-6883. [[PubMed|PubMed]] [http://www.ncbi.nlm.nih.gov/pubmed/10586089 10586089] {{Wayback|url=http://www.ncbi.nlm.nih.gov/pubmed/10586089 |date=20200518115716 }}.</ref>

===工业===
使用基因工程技术，可以用编码有用蛋白质例如酶的基因转化制造微生物（例如[[细菌|细菌]]或[[酵母|酵母]]），或转化来自多细胞生物体（例如[[昆虫|昆虫]]或[[哺乳动物|哺乳动物]]的细胞），经过转化的生物体将过表达所需的蛋白。通过使用[[发酵工程|发酵工程]]技术在生物反应器设备中生长转化的生物体，然后纯化蛋白质，可以制备大量的蛋白质。<ref>{{cite web|title=Applications of Genetic Engineering|publisher=Microbiologyprocedure|url=http://www.microbiologyprocedure.com/microbial-genetics/applications-of-genetic-engineering.htm|accessdate=2010-07-09|deadurl=yes|archiveurl=https://web.archive.org/web/20110714085807/http://www.microbiologyprocedure.com/microbial-genetics/applications-of-genetic-engineering.htm|archivedate=2011-07-14}}</ref> 一些基因在细菌中不能良好地作用，因此也可以使用酵母菌、昆虫或哺乳动物等真核生物细胞。<ref>{{cite web|title=Biotech: What are transgenic organisms?|publisher=Easyscience|year=2002|url=http://www.easyscience.co.nz/ubbiology/biotech/lesson4.htm|accessdate=2010-07-09|deadurl=yes|archiveurl=https://web.archive.org/web/20100527060202/http://www.easyscience.co.nz/ubbiology/biotech/lesson4.htm|archivedate=2010-05-27}}</ref>这些技术用于生产药物、补充剂（如[[色氨酸|色氨酸]]），帮助生产食物（乳酪制造中的[[凝乳酶|凝乳酶]]）和燃料。<ref>{{cite web|title=Making Gasoline from Bacteria: A biotech startup wants to coax fuels from engineered microbes|first=Neil|last=Savage|date=2007-08-01|url=http://www.technologyreview.com/biztech/19128/|publisher=Technology Review|accessdate=2015-07-16|archive-date=2020-04-09|archive-url=https://web.archive.org/web/20200409015344/https://www.technologyreview.com/biztech/19128/}}</ref>其它與研究中之遗传修饰细菌有所相關的应用，包括使细菌在其自然循环外进行任务，例如制造生物燃料<ref>Summers, Rebecca (24 April 2013) [http://www.newscientist.com/article/dn23431-bacteria-churn-out-first-ever-petrollike-biofuel.html Bacteria churn out first ever petrol-like biofuel] {{Wayback|url=http://www.newscientist.com/article/dn23431-bacteria-churn-out-first-ever-petrollike-biofuel.html |date=20150703025234 }} New Scientist, Retrieved 27 April 2013</ref>，清理溢油，碳和其他有毒废物<ref>{{cite web|title=Applications of Some Genetically Engineered Bacteria|url=http://www.molecular-plant-biotechnology.info/use-of-microbes-in-industry-and-agriculture/applications-of-genetically-engineered-bacteria.htm|accessdate=2010-07-09|deadurl=yes|archiveurl=https://web.archive.org/web/20101127053814/http://molecular-plant-biotechnology.info/use-of-microbes-in-industry-and-agriculture/applications-of-genetically-engineered-bacteria.htm|archivedate=2010-11-27}}</ref>，以及检测饮用水中的砷。<ref>Sanderson, Katherine (24 February 2012) [http://cen.acs.org/articles/90/web/2012/02/New-Portable-Kit-Detects-Arsenic.html New Portable Kit Detects Arsenic In Wells] {{Wayback|url=http://cen.acs.org/articles/90/web/2012/02/New-Portable-Kit-Detects-Arsenic.html |date=20131004215425 }} Chemical and Engineering News, Retrieved 23 January 2013</ref>某些遗传修饰的微生物也可以用于生物矿化和生物修复，因为它们能够从其环境中提取重金属并将其掺入更易于回收的化合物中。<ref>{{Cite book|title = Campbell Biology Ninth Edition|last = Reece|first = Jane B.|publisher = Pearson Benjamin Cummings|year = 2011|isbn = 0-321-55823-5|location = San Francisco|page=421|first2 = Lisa A.|last2 = Urry|last3 = Cain|first3 = Michael L.|last4 = Wasserman|first4 = Steven A.|last5 = Minorsky|first5 = Peter V.|last6 = Jackson|first6 = Robert B.}}</ref>
====实验室中的应用====
在材料科学中，基因修饰的病毒已经在学术实验室中用作组装更环保的锂离子电池的支架。<ref>{{cite web |url=http://web.mit.edu/newsoffice/2009/virus-battery-0402.html |title=New virus-built battery could power cars, electronic devices |publisher=Web.mit.edu |date=2009-04-02 |accessdate=2010-07-17 |archive-date=2014-03-01 |archive-url=https://web.archive.org/web/20140301024048/http://web.mit.edu/newsoffice/2009/virus-battery-0402.html |dead-url=no }}</ref><ref>{{cite web |url=http://www.npr.org/templates/story/story.php?storyId=102647672 |title=Hidden Ingredient In New, Greener Battery: A Virus |publisher=Npr.org |accessdate=2010-07-17 |archive-date=2019-05-24 |archive-url=https://web.archive.org/web/20190524081905/https://www.npr.org/templates/story/story.php?storyId=102647672 |dead-url=no }}</ref>

通过在某些环境条件下表达荧光蛋白，细菌已被設計为传感器之用。<ref>{{cite web|title=Researchers Synchronize Blinking 'Genetic Clocks' -- Genetically Engineered Bacteria That Keep Track of Time|publisher=ScienceDaily|date=2010-01-24|url=http://www.sciencedaily.com/releases/2010/01/100120131157.htm|accessdate=2017-02-10|archive-date=2019-05-20|archive-url=https://web.archive.org/web/20190520062131/https://www.sciencedaily.com/releases/2010/01/100120131157.htm|dead-url=no}}</ref>

===农业===
[[File:Bacteria_used_to_make_wheat_seeds_nearly_immune_to_wheat_take-all.jpg|thumb]]
{{main article|基因改造食物}}
基因工程最有名和有争议的应用之一是创造和使用遗传修饰作物或遗传修饰生物，如[[萤光鱼|萤光鱼]]，用于生产遗传修饰食品和具有多种用途的材料。

遗传修饰食品作物的生产有四个主要目标<ref>{{cite journal|doi=10.1111/j.1753-4887.2008.00130.x|last=Magaña-Gómez |first=JA |last2=de la Barca |first2=A.M.|year=2009|title=Risk assessment of genetically modified crops for nutrition and health|url=https://archive.org/details/sim_nutrition-reviews_2009-01_67_1/page/n4|journal=Nutr. Rev.|volume=67|issue=1|pages=1–16|pmid=19146501}}</ref>，即：耐病虫害、提高作物价值、制造副产品和加快生长强化植株。

===环境保护===
遗传工程在保护和自然区域管理中具有潜在的应用。例如，已经提出通过病毒载体的基因转移作为控制入侵物种以及接种来自疾病的受威胁动物群的手段。<ref>{{Cite journal|last=Angulo|first=E.|last2=Cooke|first2=B.|date=2002|title=First synthesize new viruses then regulate their release? The case of the wild rabbit|url=https://archive.org/details/sim_molecular-ecology_2002-12_11_12/page/2703|journal=Molecular Ecology|doi=10.1046/j.1365-294X.2002.01635.x|pmid=12453252|volume=11|pages=2703–9}}</ref>还提出了遗传修饰树作为赋予野生种群[[群体免疫|群体免疫]]的方法。<ref>{{Cite journal|last=Adams|displayauthors=etal|date=2002-08-02|title=The Case for Genetic Engineering of Native and Landscape Trees against Introduced Pests and Diseases|url=http://onlinelibrary.wiley.com/doi/10.1046/j.1523-1739.2002.00523.x/full|journal=Conservation Biology|doi=10.1046/j.1523-1739.2002.00523.x|pmid=|access-date=2016-05-16|volume=16|pages=874–879|archive-date=2017-11-11|archive-url=https://web.archive.org/web/20171111041542/http://onlinelibrary.wiley.com/doi/10.1046/j.1523-1739.2002.00523.x/full}}</ref>随着气候变化和其他扰动导致生物体适应不良的风险增加，通过基因调整促进适应可能是减少灭绝风险的一个解决方案。<ref>{{Cite journal|last=Thomas|displayauthors=etal|date=2013-09-25|title=Ecology: Gene tweaking for conservation|url=http://www.nature.com/news/ecology-gene-tweaking-for-conservation-1.13790|journal=Nature|doi=10.1038/501485a|pmid=24073449|access-date=2016-05-16|volume=501|pages=485–6|archive-date=2021-04-29|archive-url=https://web.archive.org/web/20210429091515/https://www.nature.com/news/ecology-gene-tweaking-for-conservation-1.13790}}</ref>遗传工程在保护中的应用迄今为止大部分是理论上的，还没有付诸实践。将需要进一步的实验来衡量这种做法的好处和成本。

==技术限制==

遗传工程的管理调控涉及政府为评估和管理与遗传修饰作物的开发和销售相关的风险而采取的措施。不同国家和地区针对遗传修饰作物的管理存在差异，其中美国和欧洲之间的差异最明显。根据基因工程产品的预期用途，在各国家的法规有所不同。例如，非食品用途的作物通常不由负责食品安全的机构审查。从20世纪80年代后期开始，评估包括[[联合国粮食及农业组织|粮农组织]]和[[世界卫生组织|世卫组织]]在内的组织在遗传修饰植物和食品安全方面的指导。<ref>WHO (1987): [http://www.inchem.org/documents/ehc/ehc/ehc70.htm Principles for the Safety Assessment of Food Additives and Contaminants in Food, Environmental Health Criteria 70] {{Wayback|url=http://www.inchem.org/documents/ehc/ehc/ehc70.htm |date=20191108080045 }}. World Health Organization, Geneva</ref><ref>WHO (1991): Strategies for assessing the safety of foods produced by biotechnology, Report of a Joint FAO/WHO Consultation. World Health Organization, Geneva ISBN 9789241561457. PDF download library.health.go.ug/download/file/fid/790 here]</ref><ref>WHO (1993): [http://apps.who.int/iris/bitstream/10665/61636/1/WHO_FNU_FOS_93.6.pdf Health aspects of marker genes in genetically modified plants, Report of a WHO Workshop] {{Wayback|url=http://apps.who.int/iris/bitstream/10665/61636/1/WHO_FNU_FOS_93.6.pdf |date=20160101020636 }}. World Health Organization, Geneva</ref><ref>WHO (1995): [http://apps.who.int/iris/bitstream/10665/58909/1/WHO_FNU_FOS_95.1.pdf Application of the principle of substantial equivalence to the safety evaluation of foods or food components from plants derived by modern biotechnology, Report of a WHO Workshop] {{Wayback|url=http://apps.who.int/iris/bitstream/10665/58909/1/WHO_FNU_FOS_95.1.pdf |date=20160101020636 }}. World Health Organization, Geneva</ref>

==争议==

批评者反对使用基因工程本身有几个理由，包括伦理问题<ref>{{cite web | last = Wendell | first = David | name-list-format = vanc | date = 2009-01-30 | url = http://plato.stanford.edu/entries/clinical-research/ | title = The Ethics of Clinical Research | work = The Stanford Encyclopedia of Philosophy (Fall 2012 Edition) | editor-first = Edward N. | editor-last = Zalta | access-date = 2017-02-10 | archive-date = 2022-04-14 | archive-url = https://web.archive.org/web/20220414070014/https://plato.stanford.edu/entries/clinical-research/ }}</ref><ref>{{cite web | first = Corinne | last = Segal | name-list-format = vanc | work = Tufts Daily | date = 2012-09-17 | url = http://tuftsdaily.com/archives/2012/09/17/alleged-ethics-violations-surface-in-tufts-backed-study/ | title = Alleged ethics violations surface in Tufts-backed study | access-date = 2017-02-10 | archive-date = 2022-04-14 | archive-url = https://web.archive.org/web/20220414070018/https://tuftsdaily.com/archives/2012/09/17/alleged-ethics-violations-surface-in-tufts-backed-study/ }}</ref>，生态问题<ref name="Piñeyro-Nelson_2009">{{cite journal | vauthors = Piñeyro-Nelson A, Van Heerwaarden J, Perales HR, Serratos-Hernández JA, Rangel A, Hufford MB, Gepts P, Garay-Arroyo A, Rivera-Bustamante R, Alvarez-Buylla ER | title = Transgenes in Mexican maize: molecular evidence and methodological considerations for GMO detection in landrace populations | journal = Molecular Ecology | volume = 18 | issue = 4 | pages = 750–61 | date = February 2009 | pmid = 19143938 | pmc = 3001031 | doi = 10.1111/j.1365-294X.2008.03993.x }}</ref>，与传统及有机农业的商业利益冲突，以及由于遗传修饰技术和遗传修饰生物体受知识产权法律的限制所引起的经济关注。遗传修饰生物也参与关于遗传修饰食品的争议，涉及遗传修饰作物生产的食品是否安全<ref name=Marden>{{cite web | first = Emily | last = Marden | name-list-format = vanc | url = http://lawdigitalcommons.bc.edu/cgi/viewcontent.cgi?article=2236&context=bclr | title = Risk and Regulation: U.S. Regulatory Policy on Genetically Modified Food and Agriculture | work = 44 B.C.L. Rev. 733 | date = 2003 | quote = By the late 1990s, public awareness of GM foods reached a critical level and a number of public interest groups emerged to focus on the issue.  One of the early groups to focus on the issue was Mothers for Natural Law ("MFNL"), an Iowa-based organization that aimed to ban GM foods from the market....The Union of Concerned Scientists ("UCS"), an alliance of 50,000 citizens and scientists, has been another prominent voice on the issue.... As the pace of GM products entering the market increased in the 1990s, UCS became a vocal critic of what it saw as the agency's collusion with industry and failure to fully take account of allergenicity and other safety issues. | accessdate = 2017-02-10 | archive-date = 2019-11-08 | archive-url = https://web.archive.org/web/20191108111929/http://lawdigitalcommons.bc.edu/cgi/viewcontent.cgi?article=2236&context=bclr | dead-url = no }}</ref>
，是否应该贴标签，<ref>{{cite web |url=http://www.foodstandards.gov.au/scienceandeducation/publications/consumerattitiudes |title=Consumer Attitudes Survey 2007, A benchmark survey of consumers' attitudes to food issues |publisher=Food Standards Australia New Zealand |date=January 2008 |access-date=2012-11-05 |archiveurl=https://web.archive.org/web/20110217031329/http://www.foodstandards.gov.au/scienceandeducation/publications/consumerattitiudes/ |archivedate=2011-02-17 |dead-url=no }}</ref>以及是否需要遗传修饰作物来满足世界粮食需求。<ref>{{Cite news|url = http://www.scientificamerican.com/article/sowing-a-gene-revolution/|title = Sowing a Gene Revolution|last = Raney|first = Terri|date = September 2007|work = Scientific American|access-date = 2014-10-26|last2 = Pingali|first2 = Prabhu|name-list-format = vanc|archive-date = 2022-03-10|archive-url = https://web.archive.org/web/20220310052812/https://www.scientificamerican.com/article/sowing-a-gene-revolution/}}</ref><ref name=Lal>{{cite book|editor1-first= Rattan |editor1-last= Lal |editor2-first= Peter R |editor2-last= Hobbs |editor3-first= Norman |editor3-last= Uphoff |editor4-first= David O | editor4-last = Hansen | name-list-format = vanc |title= Sustainable Agriculture and the International Rice-Wheat System |url= {{google books|plainurl=y|id=l9luzqkqj_UC |page=12}} |access-date= 2013-05-12 |year= 2004 |publisher= {{tsl|en|CRC Press||CRC Press}} |location= |isbn= 9780824754914|ref= harv  }}</ref>{{rp|12}} <ref>{{cite journal | vauthors = Kiers ET, Leakey RR, Izac AM, Heinemann JA, Rosenthal E, Nathan D, Jiggins J | title = Ecology. Agriculture at a crossroads | journal = Science | volume = 320 | issue = 5874 | pages = 320–1 | date = April 2008 | pmid = 18420917 | doi = 10.1126/science.1158390 }}</ref><ref name=IAASTD>{{cite web|title=Agriculture at a Crossroads (c) 2009"|url=http://www.unep.org/dewa/agassessment/reports/IAASTD/EN/Agriculture%20at%20a%20Crossroads_Synthesis%20Report%20(English).pdf|publisher=International Assessment of Agricultural Knowledge, Science and Technology for Development|access-date=2016-02-11|deadurl=yes|archiveurl=http://arquivo.pt/wayback/20141130191328/http://www.unep.org/dewa/agassessment/reports/IAASTD/EN/Agriculture%20at%20a%20Crossroads_Synthesis%20Report%20(English).pdf|archivedate=2014-11-30}}</ref>这些争议导致诉讼，国际贸易争端和抗议<ref name=Stutz>{{cite web | url = http://seedmagazine.com/content/article/wanted_gm_seeds_for_study | title = Wanted: GM Seeds for Study | first = Bruce | last = Stutz | name-list-format = vanc | date = 2010-07-01 | work = Seed Magazine | archive-url = https://web.archive.org/web/20100705131632/http://seedmagazine.com/content/article/wanted_gm_seeds_for_study | archive-date = 2010-07-05 | accessdate = 2017-02-10 | dead-url = no }}</ref>，以及在一些国家限制商业产品的监管。

== 注释 ==
{{NoteFoot}}

== 参考文献 ==
{{Reflist|35em}}

== 参见 ==
{{portal|生物技術|分子与细胞生物学}}
{{div col|cols=2}}
* [[基因|基因]]
* [[選殖|選殖]]
* [[基因工程历史|基因工程历史]]
* [[基因改造食品|基因改造食品]]
* [[基因轉移|基因轉移]]
* [[基因水平轉移|基因水平轉移]]
* [[基因靶向|基因靶向]]
* [[遗传工程武器|遗传工程武器]]
* [[合成生物學|合成生物學]]
* [[異源生物學|異源生物學]]
* [[BT63基因改造水稻事件|BT63基因改造水稻事件]]
* [[塞拉利尼事件|塞拉利尼事件]]
* [[螢光魚|螢光魚]]
{{div col end}}

==外部連結==
{{Commons category}}
{{Wikiquote}}
{{Library resources box |onlinebooks=no |by=no |lcheading=Genetic engineering}}
* [https://web.archive.org/web/20061213064401/http://www.gmo-safety.eu/en/ GMO Safety - Information about research projects on the biological safety of genetically modified plants.]
* [https://web.archive.org/web/20080719170701/http://www.gmo-compass.org/. GMO-compass, news on GMO en EU]
{{-}}
{{遗传学}}
{{生物技术}}
{{Genetic engineering|state=autocollapse}}
{{新兴技术}}

{{Good article}}
{{Authority control}}
[[Category:遗传学|Category:遗传学]]
[[Category:基因送递|Category:基因送递]]
[[Category:基因工程|]]
[[Category:新兴技术|Category:新兴技术]]
[[Category:生物工程|Category:生物工程]]
[[Category:生物技術|Category:生物技術]]
[[Category:分子生物学|Category:分子生物学]]